Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
esmo
Oct 23, 2023, 15:35 |
Blog
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA…
Oct 23, 2023, 15:24 |
Insight
Why radiotherapy with concomitant chemotherapy is an excellent option for bladder preservation in bladder cancer patients
Pierre Blanchard, Full Professor of Radiation Oncology at Gustave Roussy Cancer Center, posted on his…
Oct 23, 2023, 15:23 |
Drugs
Pashtoon Kasi: So excited to move the field forward with novel therapies for patients with pMMR/MSS Colorectal Cancer
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, shared on his Twitter:…
Oct 23, 2023, 13:15 |
Drugs
Pashtoon Kasi: We should drop the modified nomenclature and just agree on just dosing schema for FOLFIRINOX
Quoting Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, on X/Twitter: ''ESMO23 Moving forward…
Oct 22, 2023, 17:15 |
Blog
Advanced Oncology discussed the humanitarian crisis linked to the invasion of Artsakh with Davit Zohrabyan
Advanced Oncology shared a post on LinkedIn: “At such a big meeting like ESMO 2023…
Oct 22, 2023, 14:22 |
Blog
Myriam Chalabi: Honored to receive the Jose Baselga fellowship
Myriam Chalabi posted on her Twitter page: "Day 3 of ESMO23: early start heading to the…
Oct 22, 2023, 14:09 |
Blog
Marlene Thomas: I am particularly excited this year as Roche will be sharing data that is close to my heart!
Marlene Thomas, Head of CGP Portfolio Strategy Roche, shared a post on LinkedIn: "ESMO is…
Oct 21, 2023, 23:53 |
Blog
Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers
Peter Lebowitz, SVP, Global Oncology Therapeutic Area Head at Janssen/Johnson and Johnson, made the following…
Oct 21, 2023, 19:38 |
Blog
Top 5 Prostate abstracts not to miss by Tian Zhang
Tian Zhang, Associate Professor specialized in GU cancers at the UT Southwestern Medical Center, shared…
Oct 21, 2023, 19:37 |
Blog
Amol Akhade: Do we need to study every new IO drug against Pembrolizumab plus chemo in first line NSCLC? NO.
Amol Akhade, Senior Consultant in Medical and Hematooncology at the Dr Hitendra Patil's Suyog Cancer…
69
70
71
72
73
All:
748
Posts:
701 - 710
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube